Pope C F, Sostman H D
Invest Radiol. 1986 Aug;21(8):611-7. doi: 10.1097/00004424-198608000-00002.
The myriad of applications of indium-111 labeled platelets (111In-P), both in biomedical research and clinical diagnostic imaging, in recent years is an index of the potential of this technology. Because many diseases involve the vascular system, a nontoxic platelet label suitable for imaging has immense potential for diagnosis. Presently confined to research centers, this technique is currently used in three main diagnostic situations: deep vein thrombosis, cardiac thrombi, and organ (renal) transplantation rejection. Future applications will proliferate when difficulties in achieving rapid labeling are overcome, and the period between study initiation and final diagnosis is diminished. This review emphasizes current clinical applications and the potential role of this technology in diagnostic imaging.
近年来,铟 - 111标记血小板(111In - P)在生物医学研究和临床诊断成像中的众多应用是该技术潜力的一个指标。由于许多疾病都涉及血管系统,一种适用于成像的无毒血小板标记物在诊断方面具有巨大潜力。目前这项技术仅限于研究中心,当前主要用于三种诊断情况:深静脉血栓形成、心脏血栓以及器官(肾脏)移植排斥反应。当快速标记方面的困难被克服,且从研究开始到最终诊断的时间缩短时,未来的应用将会激增。这篇综述强调了该技术当前的临床应用及其在诊断成像中的潜在作用。